XML 29 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Information
 9 Months Ended
Sep. 30, 2018
Segment Reporting [Abstract]  
Segment Information
SEGMENT INFORMATION
 
Three Months
 
Nine Months
 
2018
2017
 
2018
2017
Orthopaedics
$
1,171

$
1,132

 
$
3,615

$
3,408

MedSurg
1,443

1,336

 
4,325

3,977

Neurotechnology and Spine
628

538

 
1,865

1,588

Net sales
$
3,242

$
3,006

 
$
9,805

$
8,973

Orthopaedics
$
397

$
390

 
$
1,263

$
1,178

MedSurg
341

272

 
968

841

Neurotechnology and Spine
173

157

 
532

446

Segment operating income
$
911

$
819

 
$
2,763

$
2,465

Items not allocated to segments:
 
 
 
 
 
Corporate and other
(104
)
(89
)
 
(291
)
(265
)
Acquisition and integration-related charges
(8
)
(11
)
 
(49
)
(29
)
Amortization of purchased intangible assets
(112
)
(92
)
 
(324
)
(275
)
Restructuring-related and other charges
(39
)
(36
)
 
(124
)
(119
)
European Medical Devices Regulation
(2
)
—

 
(5
)
—

Rejuvenate and other recall-related matters
(4
)
(66
)
 
(10
)
(164
)
Regulatory and legal matters
(66
)
—

 
(121
)
(30
)
Consolidated operating income
$
576

$
525

 
$
1,839

$
1,583


There were no significant changes to total assets by segment from information provided in our Annual Report on Form 10-K for 2017.